PALI Return on Tangible Equity | PALISADE BIO, INC.

PALISADE BIO, INC. (PALI) Return on Tangible Equity

2026-06-30: Return Tang Equity -26.27%.
2026-03-31: Return Tang Equity -18.98%.
2025-12-31: Return Tang Equity -12.99%.
2025-09-30: Return Tang Equity -366.28%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-26.27%
2026-03-31	-18.98%
2025-12-31	-12.99%
2025-09-30	-366.28%
2025-06-30	-479.00%
2025-03-31	-253.50%
2024-12-31	-196.57%
2024-09-30	-217.70%
2024-06-30	-144.61%
2024-03-31	-136.00%
2023-12-31	-110.16%
2023-09-30	-93.64%
2023-06-30	-85.89%
2023-03-31	-91.14%
2022-12-31	-115.64%
2022-09-30	-77.07%
2022-06-30	64.25%
2022-03-31	-576.79%
2021-12-31	-368.75%
2021-09-30	-846.39%
2021-06-30	436.48%
2021-03-31	59.22%
2020-12-31	61.63%
2020-09-30	60.04%
2020-06-30	65.08%
2020-03-31	69.94%
2019-12-31	92.79%
2019-09-30	-105.66%
2019-06-30	-558.89%
2019-03-31	-234.89%
2018-12-31	-93.16%
2018-09-30	-220.27%
2018-06-30	-117.61%
2018-03-31	-179.01%
2017-12-31	-205.28%
2017-09-30	-167.82%
2017-06-30	-340.65%
2017-03-31	-250.71%
2016-12-31	-203.80%
2016-09-30	418.21%
2016-06-30	7813.82%
2016-03-31	1764.26%
2015-12-31	-541.02%
2015-09-30	-243.09%
2015-06-30	-140.72%
2015-03-31	-112.40%
2014-12-31	-127.71%
2014-09-30	-97.73%
2014-06-30	-94.31%
2014-03-31	-82.39%
2013-12-31	-235.58%
2013-09-30	-232.78%
2013-06-30	-342.97%
2013-03-31	-197.74%
2012-12-31	-145.16%
2012-09-30	-109.50%
2012-06-30	-425.85%
2012-03-31	-261.77%
2011-12-31	-754.21%
2011-09-30	-325.47%
2011-06-30	-214.17%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-12.99%
2024-12-31	-196.57%
2023-12-31	-110.16%
2022-12-31	-115.64%
2021-12-31	-368.75%
2020-12-31	61.63%
2019-12-31	92.79%
2018-12-31	-93.16%
2017-12-31	-205.28%
2016-12-31	-203.80%
2015-12-31	-541.02%
2014-12-31	-127.71%
2013-12-31	-235.58%
2012-12-31	-145.16%
2011-12-31	-754.21%
2010-12-31	-234.10%
2009-12-31	206.65%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Lexeo Therapeutics, Inc. (LXEO)	United States	$0.278B	-4.19
FATE THERAPEUTICS INC (FATE)	United States	$0.280B	-2.51
Invivyd, Inc. (IVVD)	United States	$0.270B	-2.42
Liminatus Pharma, Inc. (LIMN)	United States	$0.282B
SUTRO BIOPHARMA, INC. (STRO)	United States	$0.260B	-3.05
Inhibikase Therapeutics, Inc. (IKT)	United States	$0.296B	-4.44
X4 Pharmaceuticals, Inc (XFOR)	United States	$0.297B	-4.99
SAB Biotherapeutics, Inc. (SABS)	United States	$0.306B	-25.49
Century Therapeutics, Inc. (IPSC)	United States	$0.306B	-4.02
Lineage Cell Therapeutics, Inc. (LCTX)	United States	$0.241B	-10.35